Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Early buy-in from Latinx shoppers pushes paraMi toward surprise storefront; here’s where you’ll find them soon
A physical storefront wasn’t originally part of the plan for paraMi, co-founder Veronica Alvidrez shared, until the women behind the brand listened to the needs of their community. “We knew we wanted to offer our customers a shopping experience,” Alvidrez explained. “When we did pop-up events, we realized our shoppers are tactile shoppers and they…
Is there a doctor on board? Dragon boat race puts KC professionals in the rower’s seat
Brush Creek will put teams of professionals and other competitors to the test this weekend as Kansas City’s annual Dragon Boat Festival returns to the Country Club Plaza. For at least one crew, the waterway will become a lab of sorts — with leaders evaluating their teamwork and collaboration skills. Chris Jurief, a fourth-year resident…
Scaling his superpower: How BXKC’s new app amplifies Black professionals’ connections
A new tech platform recently unveiled by Black Excellence KC is expected to provide Black entrepreneurs with resources to elevate their careers and journeys, said Craig Moore II — a move that aims to boost the group’s human capital beyond one-on-one interactions. “We’re trying to create a tool where we can create better engagement among…
New in KC: West Coast transplant impressed by local startup, tech scene; says KC should embrace more flops
Editor’s note: New in KC is an ongoing profile series that highlights newly relocated members of the Kansas City startup community, their reasons for a change of scenery, and what they’ve found so far in KC. This series is sponsored by C2FO, a Leawood-based, global financial services company. Click here to read more New in KC profiles. Kansas City is a…